Conventional immunosuppression of chronic inflammatory systemic diseases;Konventionelle Immunsuppression chronisch-entzundlicher Systemerkrankungen

Internist

Volumn 38, Issue 6, 1997, Pages 520-531

  Gross, W L ^a,b   Reinhold Keller, E ^a   Trabandt, A ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Rheumaklinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; COLCHICINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GAMMA INTERFERON; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MONOCLONAL ANTIBODY; PENICILLAMINE; PREDNISOLONE; SULFAMETHOXAZOLE; THYMOCYTE ANTIBODY; TRIMETHOPRIM; AUTOANTIBODY;

HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; REVIEW; VASCULITIS; AUTOIMMUNE DISEASE; BLOOD; CLASSIFICATION; COLLAGEN DISEASE; IMMUNOLOGY;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; COLLAGEN DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; VASCULITIS;

EID: 0030949299     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050064     Document Type: Review

References (62)

1. American College of Rheumatology task force on osteoporosis guidelines (1996) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 39:1791-1801
2. Anonymus (1996) grand round: Systemic sclerosis: current pathogenetic concepts and future prospects for targeted therapy. Lancet 247:1453-1458
3. Adams EM, Plotz PH (1995) The treatment of myositis: How to approach resistent disease. In:Cash JM, Wilder RL (eds) Treatment-rersistant rheumatic disease. WB Saunders Company, Philadelphia London Toronto, pp 179-202
4. Andrassy K, Waldherr R, Hergesell O, Ritz E (1996) Therapie der Vaskulitis. Dtsch Med Wochenschr 121:985-987
5. Boumpas DT, Austin HA, Fessier BJ, Balow JE, Klippel JH, Lockshin MD (1995) Systemic lupus erythematosus emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 122:940-950
6. Dalakas MC (1996) Clinical benefits and immunopathological correlates of intravenous immune globulin in the treatment of inflammatory myopathies. Clin Exp Immunol 104: 55-60
7. de Groot K, Reinhold-Keller E, Tatsis E, Paulsen J, Heller M, Nölle B, Gross WL (1996) Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Arthritis Rheum 39:2052-2061
8. Falk RJ, Hogan S, Carey TS, Jennette C (1990) Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulone-phritis and systemic vasculitis. Ann Intern Med 113:656-663
9. Fauci As, Haynes BF, Katz P, Wolff SM (1983) Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98:76-85
10. Ferraccioli GF, Salaffi F, De Vita S, Casatta L, Avellini C, Carotti M, Beltram CA, Cervini C, Bartoli E (1996) Interferon-alpha-2 (IFNα2) increases lacrimal and salivary function in Sjögren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine. Clin Exp Rheumatol 14:367-371
11. Fessler BJ, Boumpas DT (1995) Severe major organ involvement in systemic lupus erythematosus: diagnosis and management. Rheum Dis Clin North Am 21:81-98
12. Friedman AW, Targoff IN, Arnett FC (1996) Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Sem Arthritis Rheum 26:459-467
13. Gelber AC, Wighley FM (1995) Treatment of scleroderma. Curr Op Rheumatol 7:551-559
14. Gladman DD (1994) Indicators of disease activity, prognosis, and treatment of systemic lupus erythematosus. Curr Op Rheumatol 6: 487-492
15. Gladman DD (1996) Prognosis and treatment of systemic lupus erythematosus. Curr Op Rheumatol 8:430-437
16. Gross WL (1994) New developments in the treatment of systemic vasculitis. Curr Op Rheumatol 6:11-19
17. Gross WL, Rob PM (1996) Ciclosporin A bei entzündlich-rheumatischen Erkrankungen. Internist 37:91-97
18. Gross WL (1997) Immunopathogenesis of vasculitis. In: Klippel JH (ed) Rheumatology (2E). Mosby (in press)
19. Gourley MF, Howard AA, Scott D, Yarboro RN, Vaughan EM, Muir J, Boumpas DT, Klippel JH, Balow JE, Steinberg AD (1996) Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. Ann of Intern Med 125:549-557
20. Gulko PS, Mulloy AL (1996) Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment. Clin Exp Rheumatol 14: 199-206
21. Gumber SC, Chopra S (1995) Hepatitis C: a multifaced disease. Ann Int Med 123:615-620
22. Hagen EC, deKeizer RJW, Andrassy K, van Boven WPL, Bruijn JA, van Es LA, van der Woude FJ (1995) Compassionate treatment of Wegener's granulomatosis with rabbit antithymocyte globulin. Clin Nephrol 43:351-359
23. Hiepe F, Burmester GR (1996) Therapie des systemischen Lupus erythematodes. DMW 121:1129-1133
24. Hoffman GS, Leavitt RY, Kerr GS, Rottem M, Sneller MC, Fauci AS (1994) Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 37:578-582
25. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488-498
26. Hoffman GS, Leavitt RY, Kerr GS, Fauci AS (1990) Treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum 35:1322-1329
27. van den Hoogen FHJ, van de Putte LBA (1994) Treatment of systemic sclerosis. Curr Op Rheumatol 6:637-641
28. Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot jr., Masi AT, McShane DJ, Michel BA, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 33:1065-1067
29. Jayne RW, Lockwood CM (1996) Intravenous immunoglobulin as sole therapy for systemic vasculitis. Br J Rheum 35:1150-1153
30. Jennette CJ, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Ree AJ, van Es LA, Waldherr R, Wilk A (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37:187-192
31. Kerr G (1994) Takayasu's arteritis. Curr Op Rheumatol 6:32-38
32. Khamashta MA, Hughes GRV (1995) Antiphospholipid antibodies and antiphospholipid syndrome. Curr Op Rheumatol 7:389-394
33. Lamprecht P, Schmitt WH, Gross WL (1997) Two cases of mixed cryoglobulinemia, glomerulonephritis, and ANCA. Nephrol Dial Transp
34. Lockwood CM, Thiru S, Stewart S, Hale G, Isaacs J, Wraight P, Elliott J, Waldmann H (1996) Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies. Q J Med 89:903-912
35. Lockwood CM (1996) New treatment strategies for systemic vasculitis: the role of intravenous immune globulin therapy. Clin Exp Immunol 104:77-82
36. Mason J, Walport MJ (1992) Giant cell arteritis. BMJ 305:68-69
37. Maugars YM, Berthelot J-MM, Abbas AA, Mussini J-MB, Nguyen J-MD, Prost AM (1996) Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol 14: 263-274
38. Nesher G, Sonnenblick M, Friedlander Y (1994) Analysis of steroid related complications and mortality in temproal arteritis: a 15-year survey of 43 patients. J Rheumatol 21:1283-1286
39. Newburger JW (1996) Treatment of Kawasaki disease. Lancet 347:1128
40. Nordborg E, Nordborg C, Malmvall B-E, Andersson R, Bengtsson B-A (1995) Giant cell arteritis. Rheum Dis Clin North Am 21:1013-1026
41. Plotz PH (Moderator) NIH Conference (1995) Myositis: Immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 122:715-724
42. Reinhold-Keller E, Tatsis E, Gross WL (1996) ANCA-assoziierte Vaskulitiden (Wegener-Granulomatose, Churg-Strauss-Syndrom, Mikroskopische Polyangiitis). Z Rheumatol 54:303-309
43. Reinhold-Keller E, de Groot K, Rudert H, Nölle B, Heller M, Gross WL (1996) Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease. Q J Med 89:15-23
44. Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, Duncker G, Gross WL (1994) Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum 37:919-924
45. Richter C, Schnabel A, Csernok E, de Groot K, Reinhold-Keller E, Gross WL (1995) Treatment of ANCA-associated systemic vasculitis with high-dose intravenous immunglobulin. Clin Exp Immunol 101:2-7
46. Rostoker G, Desvaux-Belghiti D, Pilatee Y, Petit-Phar M, Philippn C, Deforges L (1994) High-dose immunoglubulin therapy for severe IgA nephropathy and Henoch-Schönlein purpura. Ann Intern Med 120:476-484
47. Savage COS, Harper L, Adu D (1997) Primary systemic vasculitis. Lancet 349:553-558
48. Schmitt WH, Haubitz M, Mistry N, Brunkhorst R, Erbslöh-Möller B, Gross WL (1993) Renal transplantation in Wegener's granulomatosis. Lancet 342:860
49. Schröder JO (1996) Behandlung des systemischen Lupus erythematodes. Akt Rheumatol 21:89-97
50. Schröder JO, Schwab UM, Schnabel A, Asbeck F, Zurborn KH, Gross WL, Euler HH (1996) Häufung MTX-assoziierter Zytopenien bei älteren Menschen. Dtsch Ärztebl 93:321-322
51. Sneller MC, Hoffman GS, Talar-Williams C, Kerr GS, Hallahan CW, Fauci AS (1995) An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum 38:608-613
52. Stegeman CA, Cohen Tervaert JWC, de Jong PE, Kallenberg CGM (1996) Trimethoprim-Sulfamethoxazole (Co-Trimoxazole) for the prevention of relapse of Wegener's granulomatosis. N Engl J Med 335:16-20
53. Steinberg AD, Gourley M (1995) Cyclophosphamide in lupus nephritis. J Rheumatol 22: 1812-1814
54. Szer IS (1996) Henoch-Schönlein purpura: when and how to treat. J Rheumatol 23: 1661-1665
55. Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Hallahn CW, Lubensky I, Kerr GS, Hoffman GS, Fauci AS, Sneller MC (1996) Cyclophosphamide induced cystitis and bladder cancer in patients with Wegener's granulomatosis. Ann Intern Med 124:477-484
56. Tatsis E, Mühler M, Schnabel A, Reinhold-Keller E, Gross WL (1996) Treatment of Churg-Strauss syndrome with interferon alpha. Arthritis Rheum 39:64
57. Vallance DK, Lynch JP, McCune WJ (1995) Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis. Curr Op Rheum 7:174-182
58. Villalba L, Adams EM (1996) Update on therapy for refractory dermatomyositis and polymyositis. Curr Op Rheumatol 8:544-551
59. Vlachoyiannopoulos PG, Tsifetaki N, Dimitriou I, Galaris D, Papiris SA, Moutsopoulos HM (1996) Safety and efficacy of recombinant γ-Interferon in the treatment of systemic sclerosis. Ann Rheum Dis 55:761-768
60. Weite K, Gabrilove J, Bronchud M, Platzer E, Mortsyn G (1996) Filgrastim (r-metHuG-CSF):The first 10 years. Blood 88:1907-1929
61. White B, Bauer EA, Goldsmith LA, Hochberg MC, Katz LM, Korn JH, Lachenbruch PA, LeRoy EC, Mitrane MP, Paulus HE, Postlethwaite AE, Steen VD (1995) Guidelines for clinical trials in systemic sclerosis. Arthritis Rheum 38:351-360
62. Wilke WS, Hoffman GS (1995) Treatment of corticosteroid resistant giant cell arteritis. Rheum Dis Clin North Am 21:59-71